Oriental Hotels reported standalone revenue of Rs 116.80 crore for Q2 FY27, up from Rs 109.65 crore a year ago. The company’s net profit for the period stood at Rs 11.62 crore. Investors are primarily tracking the ongoing scheme of arrangement to amalgamate the company into The Indian Hotels Company Limited, which remains subject to NCLT and regulatory approvals.
Oriental Hotels Reports Q2 FY27 Financials Amid Merger Progress
Revenue grew to Rs 116.80 crore from Rs 109.65 crore; net profit stood at Rs 11.62 crore.
Reader Takeaway: Revenue growth highlights steady core operations, though merger-related costs and NCLT approval timelines remain primary focus areas.
What just happened
Oriental Hotels released its standalone and consolidated financial results for the quarter ended September 30, 2026. The company reported a standalone revenue of Rs 116.80 crore, marking an increase from the Rs 109.65 crore recorded in the same period last year. Profit after tax for the quarter was reported at Rs 11.62 crore, compared to Rs 12.66 crore in the year-ago quarter. The results were reviewed by the Audit Committee and received an unmodified review report from the statutory auditors, PKF Sridhar & Santhanam LLP.
Why this matters
The company is currently in the process of an amalgamation into The Indian Hotels Company Limited (IHCL). The board reiterated its commitment to this scheme, which was initially approved on August 24, 2026. The financial results include an exceptional expense of Rs 0.70 crore linked specifically to these merger proceedings, reflecting the administrative and legal costs involved in the transition.
What changes now
Operational focus remains on the hoteliering business, which constitutes the company's sole segment. While quarterly operations remain steady, the primary shift for shareholders is the transition toward becoming part of the IHCL entity. All further progress remains strictly contingent upon receiving formal sanctions from the relevant NCLT bench, along with necessary approvals from shareholders and creditors.
Risks to watch
The key uncertainty for investors lies in the regulatory and judicial timeline. Delays in the NCLT approval process or potential feedback from statutory bodies could impact the anticipated completion timeline of the merger. Additionally, the company continues to incur merger-related expenses, which are recorded as exceptional items in the profit and loss statement.
What to track next
Investors should monitor official stock exchange filings for updates regarding NCLT hearing dates and any subsequent regulatory clearances required to finalize the scheme of arrangement with IHCL.
